|
|
||||||||
The role played by cyclic AMP (cAMP)-dependent protein kinases (PKAs) in rat adrenal steroidogenesis has been investigated using cAMP analogues which show partial selectivity for the type I and type II PKA isoenzymes. These were aminohexylamino-cAMP (AHA-cAMP; selective for site 1 on type I PKA), N6-benzoyl-cAMP (BZ-cAMP; selective for site 2 on PKA types I and II) and 8-thiomethyl-cAMP (TM-cAMP; selective for site 1 on type II PKA). Positive cooperativity exists between the two nucleotide-binding sites, thus the presence of type I PKA was inferred when synergistic increases in corticosteroid production were obtained with AHA-cAMP plus BZ-cAMP and that of type II PKA when synergistic increases were obtained with TM-cAMP plus BZ-cAMP.
The effects of AHA-cAMP, TM-cAMP and BZ-cAMP (10–100 µmol/l) on aldosterone production by glomerulosa cell preparations and corticosterone production by fasciculata/reticularis cell preparations were compared. Dose-related stimulation of steroid production was obtained with each cAMP analogue in both types of cell preparation. Experiments were performed using the cAMP analogues in combination at doses which gave minimal stimulation individually. Cells were incubated with AHA-cAMP (66 and 100 µmol/l) or TM-cAMP (15, 30 and 45 µmol/l) in the presence and absence of 15µmol BZ-cAMP/l. Synergistic responses were obtained with both analogue pairs in both cell types. The synergism ratio in fasciculata/reticularis cell preparations for the type I PKA selective pair of analogues (100 µmol AHA-cAMP/l plus 15µmol BZ-cAMP/l) was significantly higher (P<0·01) than that for the type II selective pair (45µmol TM-cAMP/l plus 15µmol BZ-cAMP/l; 7·9±1·2 (mean±S.E.M.) and 2·6±0·3 respectively). In zona glomerulosa preparations the ratio was higher (P<0·05) for the type II selective pair (1·6±0·1 for AHA-cAMP plus BZ-cAMP and 2·8±0·4 for TM-cAMP plus BZ-cAMP).
The effects of 100µmol AHA-cAMP/l and 45µmol TM-cAMP/l on the response to ACTH (1 pmol/l–10 nmol/l) were examined. Synergistic responses were obtained in fasciculata/reticularis cells with both analogues in combination with low concentrations of ACTH (10 and 100 pmol/l). In zona glomerulosa cells only the addition of TM-cAMP (45 µmol/l) in combination with 10 pmol ACTH/1 gave rise to synergistic increases in aldosterone production, which suggests that there may be some compartmentalization of the cAMP-dependent pathway in these cells.
The results indicate that both isoenzymes of PKA are present in rat adrenocortical cells and can play a part in the control of steroidogenesis. Type I PKA activity appears dominant in the control of zona fasciculata/reticularis cell function whereas modulation of type II PKA activity plays a more significant role in the responses of zona glomerulosa cells.
This article has been cited by other articles:
![]() |
M. Wirtenberger, J. Schmutzhard, K. Hemminki, A. Meindl, C. Sutter, R. K. Schmutzler, B. Wappenschmidt, M. Kiechle, N. Arnold, B. H.F. Weber, et al. The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer Carcinogenesis, February 1, 2007; 28(2): 423 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, R. K. Sunahara, A. Krumins, G. Perkins, M. L. Crochiere, M. Mackey, S. Bell, M. H. Ellisman, and S. S. Taylor Cloning and mitochondrial localization of full-length D-AKAP2, a protein kinase A anchoring protein PNAS, March 13, 2001; 98(6): 3220 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qi, C.-M. Hao, K. Salter, R. Redha, and M. D. Breyer Type II cAMP-dependent protein kinase regulates electrogenic ion transport in rabbit collecting duct Am J Physiol Renal Physiol, April 1, 1999; 276(4): F622 - F628. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Steagall, T. J. Kelley, R. J. Marsick, and M. L. Drumm Type II protein kinase A regulates CFTR in airway, pancreatic, and intestinal cells Am J Physiol Cell Physiol, March 1, 1998; 274(3): C819 - C826. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |